Subconjunctival dexamethasone in routine cataract surgery

Phase 4

• Conditions: Cataract; Eye - Diseases / disorders of the eye; Surgery - Surgical techniques

• Registration Number: ACTRN12613000314729
• Lead Sponsor: The Alfred

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-03-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

Patients with visually debilitating cataracts requiring surgery

Exclusion Criteria

Patients with a history of other ocular pathologies or other abnormal ocular examinations

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post-operative ocular inflammation (using slit-lamp examination)[1 month post-operatively];Macular oedema (using optical coherence tomography)[1 month post-operatively]

Secondary Outcome Measures

Name	Time	Method
evel of participant comfort during and following cataract surgery (using a questionnaire with a visual analogue scale)[1 day post-operatively];Complications of surgery (determined by clinical examination) e.g. retinal detachment, uveitis, endophthalmitis[1 month post-operatively]